Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-840-4 | CAS number: 160583-22-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin irritation / corrosion
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Additional information
Skin irritation
A study equivalent to OECD 439 (In Vitro Skin Irritation) was performed to assess the skin irritation properties of 2-phenylethyl cyanoacrylate. 2-Phenylethyl cyanoacrylate showed virtually no effects on the skin models, resulting in a mean viability of the tissues of about 97 % compared to the negative control. According to this result, 2 -phenylethyl cyanoacrylate is considered to be non-irritant.
The study result is in line with several clinical investigations that demonstrate the well-established use of long chain alkyl 2 -cyanoacrylates, e.g. 2-octyl cyanoacrylate as an effective alternative to conventional sutures in closing surgical incisions in humans. Such tissue adhesives are used in different procedures including general surgery, emergency medicine and plastic surgery. The adhesive polymerizes in contact with tissue surfaces in an exothermic reaction in 30-60 sec. From the overall clinical experience, it was concluded that the use of 2-octyl cyanoacrylate is successful, safe and well accepted by patients. No adverse health implications with regard to skin irritation have been described in these publications.
Eye irritation
The eye irritation properties of 2 -phenylethyl cyanoacrylate were assessed by an HET-CAM study using the endpoint assessment method. According to the irritation score which was found to be 0, 2 -phenylethyl cyanoacrylate did not induce any irritative effects.
It was observed during the study that the substance builds a polymeric sticky sheet on the CAM that can be removed without significantly damaging the CAM by using forceps. This observation indicates that testing of 2-phenylethyl cyanoacrylate in vivo might result in irritative effects based on the fact that solid polymeric particles will constantly scratch the eye's surface. It is therefore concluded that an in vivo study is not justified in this case.
The result on eye irritation for 2 -phenylethyl cyanoacrylate are in line with a variety of clinical investigations that demonstrate the successful use of the homologeous 2-octyl cyanoacrylate as effective tissue adhesive in medical treatments such as blepharoplasty, facial skin closure, cleft lip repair, laparoscopic surgery wound closure, and the treatment of gastric fundal varices (see Meskin et al. 2005). The application of cyanoacrylate adhesives has become standard therapy for small corneal perforations due to their ease of use and application and ability to delay surgical therapy. In those cases, the adhesive is directly applied into the eye.
Although the publications do not cover large clinical trials, the case studies presented do give an indication on the behaviour of the tissue adhesive on eyes.The studies conclude that 2-octyl cyanoacrylate can well be used as wound barrier in ocular (and skin) surgery with a low side effect profile. Reversible eye irritation was reported occasionally. Some patients complained of mild transient foreign body sensation on postoperative day 1. Others had trace diffuse bulbar conjunctival hyperemia or trace focal conjunctival hyperemia adjacent to the wound. However, conjunctival injection, mild corneal edema, or anterior chamber cellular reaction were not more significant than those seen in other routine surgery cases. Irritation was not mentioned in any of the publications as contraindication for the use of 2-octyl cyanoacrylate in eye surgery.
Justification for classification or non-classification
Skin irritation
Based on the in vitro skin irritation study performed with 2 -phenylethyl cyanoacrylate, and considering the overall weight-of-evidence resulting from other cyanoacrylate homologues, it is concluded that 2-phenylethyl cyanoacrylate is not classified as irritating to the skin.
Eye irritation
Based on the HET-CAM study performed with 2 -phenylethyl cyanoacrylate, and considering the overall weight-of-evidence
resulting from other cyanoacrylate homologues, it is also concluded that 2-phenylethyl cyanoacrylate is not classified as irritating to the eyes.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.